Appointments of Hongjuan Liu and Mark Czajkowski follow Manulife’s recent re-domiciliation and ongoing investment in AI and data initiatives in the region.
Subsidiary of property conglomerate had its ratings affirmed, with AM Best noting a shift in its investment portfolio towards cash and high-grade fixed income assets.
Group’s record 2025 results set the stage for a pivotal year ahead, as the pan-Asian life insurer bets on AI, expansion across China’s provinces, and deepening wealth partnerships.
China's market is heading toward half a trillion dollars by 2035, and insurers face the high-frequency challenge of flight safety, data security, and infrastructure risk—compounded by the threat of low-probability,...
The W&I product expansion looks to address both historical and future risks with "predictable cost structure" for cyber, environmental, D&O, and crisis management add-on covers.
While bancassurance new business profit powered Prudential's FY2025 growth, the group has flagged transforming the agency channel as its "number one priority".
The deal sees BP Marsh exit Amiga while retaining a stake in Sodalis and reunites Amiga CEO Adam Kembrooke with Sodalis CEO Colin Thompson, former colleagues at Nexus.
Fitch has identified correlated aggregation risk as the key near-term concern for specialty insurers, even as the agency maintains a broadly contained ratings outlook.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
